CADENCE PHARMACEUTICALS INC: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2013)
- $112.6M
- Net Income/Loss (FY2013)
- -$24.3M
- Total Assets (FY2013)
- $90.8M
- Total Equity (FY2013)
- $34.9M
- Cash Flows from Operating Activities (FY2013)
- -$23.2M
Source: CADENCE PHARMACEUTICALS INC 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
